Potential candidates are CAG repeat length, blood neurofilament light chain (NfL) concentrations, MRI volume measures, magnetic resonance spectroscopic (MRS) metabolites, digital measures of gait variability and– in SCA2– sensory nerve amplitudes. The gene discussed is NEFL; the disease is spinocerebellar ataxia type 2.